About Estech
Estech is a company based in San Ramon (United States) founded in 1996 was acquired by AtriCure in December 2013. Estech has raised $39 million across 3 funding rounds from investors including AtriCure, Waveland Capital Group and Saints Capital. Estech operates in a competitive market with competitors including AtaCor Medical, Kestra Medical Technologies, CardioFocus, AtriCure and TyRx, among others.
- Headquarter San Ramon, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Estech
Estech has successfully raised a total of $39M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $8.5 million completed in December 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Estech
Estech has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include AtriCure, Waveland Capital Group and Saints Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Direct secondary investments are made in private company shares.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Locked | Locked | Locked | |
|
Healthcare investments are made by Tullis Health Investors.
|
Locked | Locked | Locked |
Investor details for Estech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Estech
Investment portfolio details for Estech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Estech
Detailed financials for Estech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Estech Comparisons
Peer comparison for Estech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Estech
Estech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtaCor Medical, Kestra Medical Technologies, CardioFocus, AtriCure and TyRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An implantable pacemaker system is developed for cardiac pacing therapy.
|
|
| Locked | Locked | Locked |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| Locked | Locked | Locked |
Endoscopic catheter for atrial fibrillation ablation is developed.
|
|
| Locked | Locked | Locked |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| Locked | Locked | Locked |
Antibacterial envelopes are developed for stabilizing cardiac implantable devices.
|
|
| Locked | Locked | Locked |
Non-invasive treatments for cardiac arrhythmias are developed by EBAMed.
|
Detailed competitors of Estech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Estech
Complete news archive for Estech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Estech
Estech was founded in 1996 and raised its 1st funding round 12 years after it was founded.
Estech is headquartered in San Ramon, United States. It is registered at San Ramon, California, United States.
Estech is a funded company, having raised a total of $39M across 3 funding rounds to date.
Estech was founded in 1996 in San Ramon, United States, and operated in the medical devices sector for cardiac surgery. A portfolio of minimally invasive and hybrid ablation devices was offered, including temperature-controlled RF energy delivery, Versapolar technology for bipolar and monopolar energy, suction-applied tissue contact, and internally-cooled options. The company was acquired by AtriCure in 2013.
Estech's top competitors include AtaCor Medical, AtriCure and CardioFocus.
Estech has 6 investors. Key investors include AtriCure, Waveland Capital Group, Saints Capital, Telegraph Hill Partners, and Tullis Health Investors.